OTC Markets OTCPK - Delayed Quote USD

4DMedical Limited (FDMDF)

Compare
0.3400
0.0000
(0.00%)
At close: January 17 at 3:00:00 PM EST

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Andreas Fouras M.A.I.C.D., Ph.D. Founder, MD, CEO & Director 574.29k -- --
Mr. Simon Glover Chief Financial Officer 270.39k -- --
Mr. Matt Tucker Chief Commercial Officer 341.42k -- --
Ms. Naomi Lawrie Company Secretary & General Counsel -- -- --
Dr. Aidan Jamison B.E., Ph.D. Senior Vice President of Engineering -- -- --
Ms. Rachael Tenkaten Senior Vice President of Product -- -- --
Dr. Greg T. Mogel M.D. Chief Medical Officer -- -- --
Mr. David Hannes B.S., M.B.A. Senior Vice President of Global Business Development -- -- --

4DMedical Limited

Melbourne Connect
Level 7 700 Swanston Street
Carlton, VIC 3053
Australia
61 3 9545 5940 https://4dmedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
145

Description

4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.

Corporate Governance

4DMedical Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 26, 2025 at 10:59 AM UTC - March 3, 2025 at 12:00 PM UTC

4DMedical Limited Earnings Date

Recent Events

Related Tickers